公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies | Shimizu T.; Kuboki Y.; CHIA-CHI LIN ; Yonemori K.; Yanai T.; Faller D.V.; Dobler L.; Gupta N.; Sedarati F.; Kim K.-P. | Targeted Oncology | 5 | 5 | |
2021 | Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs | Hata T.; Nakamura K.; Yonemori K.; Noguchi E.; Watanabe M.; Sohn J.; YEN-SHEN LU ; Yap Y.-S.; Tamura K.; Fujiwara Y. | Clinical and Translational Science | 2 | 1 |